Treatment for SMARCA4-deficient carcinoma of uterine cervix
Authors:
- 4 January 2025
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 18 (1) , e258711
Abstract
SMARCA4-deficient undifferentiated cervical carcinoma is an extremely rare and aggressive malignancy, and effective treatment options are lacking. We experienced a rare case involving a patient with SMARCA4-deficient undifferentiated cervical carcinoma who was successfully managed in the long term. A woman in her 40s presented with a chief complaint of abnormal vaginal bleeding. A cervical biopsy revealed adenocarcinoma; thus, radical hysterectomy was performed with R0 tumour resection. Histopathological examination of the resected tumour showed rhabdoid features under (H&E) staining and negativity for SMARCA4 under immunohistochemical staining. Given the poor prognosis associated with SMARCA4-deficient carcinoma, adjuvant radiotherapy was added. Follow-up for more than a year revealed no evidence of recurrence. For undifferentiated cervical carcinoma with rhabdoid features on H&E staining, SMARCA4 immunostaining may be considered for risk classification and recurrence prevention. R0 resection and postoperative adjuvant radiotherapy may contribute to a good prognosis for patients with SMARCA4-deficient carcinoma.Keywords
This publication has 13 references indexed in Scilit:
- SMARCA4-deficient Undifferentiated Uterine Sarcoma: Clinicopathological Features of an Emerging EntityInternational Journal of Surgical Pathology, 2022
- SWI/SNF-deficient malignancies of the female genital tractSeminars in Diagnostic Pathology, 2021
- Role of SMARCA4 (BRG1) and SMARCB1 (INI1) in Dedifferentiated Endometrial Carcinoma With Paradoxical Aberrant Expression of MMR in the Well-Differentiated Component: A Case Report and Review of the LiteratureInternational Journal of Surgical Pathology, 2020
- SMARCA4-deficient uterine sarcoma: A case report and a concise reviewCase Reports in Women's Health, 2020
- SMARCA family of genesJournal of Clinical Pathology, 2020
- SMARCA4-Deficient Thoracic Sarcoma: A Case Report and Review of LiteratureInternational Journal of Surgical Pathology, 2019
- CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovaryNature Communications, 2019
- SMARCA4-deficient undifferentiated carcinoma of the ovary (small cell carcinoma, hypercalcemic type): clinicopathologic and immunohistochemical study of 3 casesAnnals of Diagnostic Pathology, 2015
- Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic typeNature Genetics, 2014
- New Gynecologic Cancer StagingGynecologic Oncology, 1995